2021 Africa Tier 2 GHG Inventory Development Region UG, ZM & ZIM plus KY & MW- Unique - AgResearch Limited own the Developed IP and Unique have granted a license (royalty free, non-exclusive, sub-licensable, transferrable, perpetual) to use Background IP for any purpose.

2021 Africa Tier 2 GHG Inventory Development Region UG, ZM & ZIM- PRIME - AgResearch Limited own the Developed IP and Unique have granted a license (royalty free, non-exclusive, sub-licensable, transferrable, perpetual) to use Background IP for any purpose.

2022 Philippines Program - Cattle UPLB, own the IP but we are granted a license (royalty free, non-exclusive, sub-licensable, transferrable, perpetual) to use this data for any non-commercial purpose.

TO RELEASE VIETNAM PROGRAMME DEVELOPED IP WE MUST OBTAIN MPI APPROVAL IN WRITING TO INCLUDE DATA FROM THE FOLLOWING:
2022-Vietnam Program - NIAS - developed IP is owned by MPI with no license granted to use.  

2022-Vietnam Program - CAAS (collaborated with the NIAS contract) - AgResearch Limited own the IP and grant MPI a license (royalty free, non-exclusive, sub-licensable, transferrable, perpetual) to use this data for any non-commercial purpose.

TO RELEASE INDONESIAN PROGRAMME DEVELOPED IP WE MUST OBTAIN APPROVAL IN WRITING DUE TO THE FOLLOWING:
2022 Indonesia Program - BRIN - Background IP ownership retained by original owners. Developed IP is jointly owned by the Parties unless identified in the IP register, held with the Contractor. Developed IP must have written permission to release from all Parties and Commercialsable IP must be disclosed to the Parties at the End of the Contract. For 6 months from the contract End Date, release of Developed IP identified as Commercialsable must have written permission to release from all Parties. After the six-month period, Developed IP where the Parties do not jointly own Developed IP, and the Contractor has not made a protective application for any Commercialsable IP, MPI or other sector agencies will be granted a license (irrevocable, royalty free, non-exclusive, license to use, copy and disseminate that Commercialisable IP in any manner not consistent with the terms of the Protective Application and any subsequently obtained as a result of such application.)

AS DEVELOPED IP INCLUDES ANY DELIVERABLE UNDER THE CONTRACT, DR HEGARTY AND Dr PACHECO MUST OBTAIN TH E CORRECT WRITTEN PERMISSIONS PRIOR TO THE CSA DATA RELEASE TO UDC